FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2025-83-60.46%
Mar 31, 2024-210+23.90%
Mar 31, 2023-170+177.64%
Mar 31, 2022-61+0.48%
Mar 31, 2021-61-71.52%
Mar 31, 2020-214-15.56%
Mar 31, 2019-253+19.84%
Mar 31, 2018-211-35.74%
Mar 31, 2017-328-51.25%
Mar 31, 2016-674+232.63%
Mar 31, 2015-203
AI Chat